Protein acylations in cancer immunity: effects and therapeutic opportunities

Jia-Cheng Lai1, Yi-Ting Jiang1, Shougeng Liu1

  • 1Department of Pharmacology, Shenyang Pharmaceutical University; Shenyang, 110016, PR China; Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University; Benxi, 117004, PR China.

Insights

Acylations, such as acetylation and lactylation, impact cancer immunity and the tumor immune microenvironment (TIME). Targeting these modifications offers therapeutic potential to enhance antitumor immune responses.

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • Acylations are crucial post-translational modifications regulating gene transcription and protein function.
  • These modifications are implicated in various diseases, including cancers.
  • Acylations' reversible nature presents therapeutic opportunities by targeting regulatory enzymes.

Purpose of the Study:

  • To review the impact of various acylations on cancer immunity.
  • To explore therapeutic strategies targeting acylations for cancer treatment.
  • To highlight the interplay between acylations and the tumor immune microenvironment (TIME).

Main Methods:

  • Literature review of acylation types (acetylation, lactylation, palmitoylation, etc.).
  • Analysis of acylation roles in cancer immunity.
  • Examination of therapeutic targets related to acylation.

Main Results:

  • Acylations significantly influence the TIME and antitumor immunity.
  • Specific acylation types and their regulatory enzymes have distinct roles.
  • Targeting acylations can modulate immune responses within the tumor microenvironment.

Conclusions:

  • Acylation manipulation is a promising strategy to enhance antitumor immunity.
  • Understanding diverse acylation roles can guide novel cancer therapies.
  • Further research into acylation-related enzymes and metabolites is warranted for therapeutic development.

Related Concept Videos

Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
381
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K